SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-05-000327
Filing Date
2005-12-12
Accepted
2005-12-12 15:55:34
Documents
2
Period of Report
2005-12-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 THERAVANCE 8K theravance8k.htm 8-K 4421
2 THERAVANCE PRESS RELEASE theravanceinc8k1036.htm EX-99 4515
  Complete submission text file 0001102624-05-000327.txt   10594
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 051258246
SIC: 2834 Pharmaceutical Preparations